Age-specific differences in non-cardiac comorbidities among elderly patients hospitalized with heart failure: a special focus on young-old, old-old, and oldest-old.
Journal
Chinese medical journal
ISSN: 2542-5641
Titre abrégé: Chin Med J (Engl)
Pays: China
ID NLM: 7513795
Informations de publication
Date de publication:
20 Dec 2019
20 Dec 2019
Historique:
pubmed:
7
12
2019
medline:
10
7
2020
entrez:
7
12
2019
Statut:
ppublish
Résumé
Despite the growing epidemic of heart failure (HF), there is limited data available to systematically compare non-cardiac comorbidities in the young-old, old-old, and oldest-old patients hospitalized for HF. The precise differences will add valuable information for better management of HF in elderly patients. A total of 1053 patients aged 65 years or older hospitalized with HF were included in this study. Patients were compared among three age groups: (1) young-old: 65 to 74 years, (2) old-old: 75 to 84 years, and (3) oldest-old: ≥85 years. Clinical details of presentation, comorbidities, and prescribed medications were recorded. The mean age was 76.7 years and 12.7% were 85 years or older. Most elderly patients with HF (97.5%) had at least one of the non-cardiac comorbidities. The patterns of common non-cardiac comorbidities were different between the young-old and oldest-old group. The three most common non-cardiac comorbidities were anemia (53.6%), hyperlipidemia (45.9%), and diabetes (42.4%) in the young-old group, while anemia (73.1%), infection (58.2%), and chronic kidney disease (44.0%) in the oldest-old group. Polypharmacy was observed in 93.0% elderly patients with HF. Additionally, 29.2% patients were diagnosed with infection, and 67.0% patients were prescribed antibiotics. However, 60.4% patients were diagnosed with anemia with only 8.9% of them receiving iron repletion. Non-cardiac comorbidities are nearly universal in three groups but obviously differ by age, and inappropriate medications are very common in elderly patients with HF. Further treatment strategies should be focused on providing optimal medications for age-specific non-cardiac conditions.
Sections du résumé
BACKGROUND
BACKGROUND
Despite the growing epidemic of heart failure (HF), there is limited data available to systematically compare non-cardiac comorbidities in the young-old, old-old, and oldest-old patients hospitalized for HF. The precise differences will add valuable information for better management of HF in elderly patients.
METHODS
METHODS
A total of 1053 patients aged 65 years or older hospitalized with HF were included in this study. Patients were compared among three age groups: (1) young-old: 65 to 74 years, (2) old-old: 75 to 84 years, and (3) oldest-old: ≥85 years. Clinical details of presentation, comorbidities, and prescribed medications were recorded.
RESULTS
RESULTS
The mean age was 76.7 years and 12.7% were 85 years or older. Most elderly patients with HF (97.5%) had at least one of the non-cardiac comorbidities. The patterns of common non-cardiac comorbidities were different between the young-old and oldest-old group. The three most common non-cardiac comorbidities were anemia (53.6%), hyperlipidemia (45.9%), and diabetes (42.4%) in the young-old group, while anemia (73.1%), infection (58.2%), and chronic kidney disease (44.0%) in the oldest-old group. Polypharmacy was observed in 93.0% elderly patients with HF. Additionally, 29.2% patients were diagnosed with infection, and 67.0% patients were prescribed antibiotics. However, 60.4% patients were diagnosed with anemia with only 8.9% of them receiving iron repletion.
CONCLUSIONS
CONCLUSIONS
Non-cardiac comorbidities are nearly universal in three groups but obviously differ by age, and inappropriate medications are very common in elderly patients with HF. Further treatment strategies should be focused on providing optimal medications for age-specific non-cardiac conditions.
Identifiants
pubmed: 31809320
doi: 10.1097/CM9.0000000000000560
pmc: PMC6964950
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2905-2913Références
JAMA. 2010 Nov 3;304(17):1950-1
pubmed: 21045104
Eur Heart J. 2015 Mar 14;36(11):657-68
pubmed: 25176939
J Am Coll Cardiol. 2018 Feb 20;71(7):782-793
pubmed: 29447741
Circulation. 2017 Feb 21;135(8):759-771
pubmed: 28052979
Circulation. 2019 May 21;139(21):2386-2398
pubmed: 30776909
Eur J Heart Fail. 2014 Jul;16(7):817-25
pubmed: 24828035
J Am Coll Cardiol. 2008 Sep 2;52(10):818-27
pubmed: 18755344
Arch Intern Med. 2008 Apr 28;168(8):847-54
pubmed: 18443260
Circulation. 2018 Mar 20;137(12):e67-e492
pubmed: 29386200
Eur Heart J. 2009 Feb;30(4):478-86
pubmed: 19106198
Eur Heart J. 2019 Feb 21;40(8):651-661
pubmed: 30778534
Lancet. 2018 Feb 10;391(10120):572-580
pubmed: 29174292
Circulation. 2018 Jul 3;138(1):80-98
pubmed: 29967232
Blood. 2018 Feb 1;131(5):505-514
pubmed: 29141943
J Am Geriatr Soc. 2016 Jul;64(7):1469-74
pubmed: 27348135
Chin Med J (Engl). 2019 Feb 5;132(3):352-355
pubmed: 30681504
J Am Coll Cardiol. 2003 Oct 1;42(7):1226-33
pubmed: 14522486
Eur Heart J. 2006 Nov;27(22):2725-36
pubmed: 17000631
JAMA. 2008 Dec 24;300(24):2867-78
pubmed: 19109115
Eur J Heart Fail. 2014 Jan;16(1):103-11
pubmed: 24453099
J Card Fail. 2017 Jun;23(6):464-475
pubmed: 28433667
Stroke. 2017 May;48(5):1161-1168
pubmed: 28377383
Zhonghua Xin Xue Guan Bing Za Zhi. 2010 Mar;38(3):195-208
pubmed: 20450560
Circ Heart Fail. 2018 Jun;11(6):e004646
pubmed: 29793934
Chin Med J (Engl). 2016 Jan 5;129(1):22-7
pubmed: 26712428
Am J Med. 2011 Feb;124(2):136-43
pubmed: 21295193
Circ Heart Fail. 2011 Jan;4(1):27-35
pubmed: 21068341
J Am Coll Cardiol. 2012 Mar 13;59(11):998-1005
pubmed: 22402071
J Am Coll Cardiol. 2007 Mar 6;49(9):963-71
pubmed: 17336720
Eur J Heart Fail. 2002 Jan;4(1):91-8
pubmed: 11812669
Eur J Heart Fail. 2018 Jan;20(1):125-133
pubmed: 28436136
J Am Coll Cardiol. 2016 May 24;67(20):2419-2440
pubmed: 27079335
Circulation. 2015 Oct 6;132(14):1347-53
pubmed: 26316616
J Am Coll Cardiol. 2018 May 1;71(17):1921-1936
pubmed: 29699619
Int J Cardiol. 2014 Aug 20;175(3):464-72
pubmed: 25005339
Eur J Intern Med. 2017 Jan;37:56-63
pubmed: 27692931
Chin Med J (Engl). 2018 Sep 5;131(17):2032-2040
pubmed: 30127212
Lancet. 2014 Jan 18;383(9913):245-54
pubmed: 24449944